Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Tectonic Therapeutic Inc TECX

Healthcare Biotechnology
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the... see more

Current News (NDAQ:TECX)

Tectonic Therapeutic to Participate in December Investor Conferences

GlobeNewswire December 1, 2025

Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire November 6, 2025

Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF

GlobeNewswire October 29, 2025

Tectonic Therapeutic to Participate in September Investor Conferences

GlobeNewswire August 28, 2025

Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire August 7, 2025

Tectonic Therapeutic Joins Russell 3000® Index

GlobeNewswire June 30, 2025

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025

GlobeNewswire May 17, 2025

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire May 8, 2025

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference

GlobeNewswire May 7, 2025
View More News ››

Opinion & Analysis (NDAQ:TECX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TECX)

Sell buddy sell.

Otherwise you guys out there will be losing your shorts with this stock today anyway
coolfooldumbguy - September 2, 2025
View more Bullboard ››

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp., an exploration stage company, engages in the acquisition and exploration of mineral ...
View More »

Podcasts